![Table 2 from Conversion from epoetin alfa to darbepoetin alfa: effects on patients' hemoglobin and costs to canadian dialysis centres. | Semantic Scholar Table 2 from Conversion from epoetin alfa to darbepoetin alfa: effects on patients' hemoglobin and costs to canadian dialysis centres. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/84246e2eeb4dcef6ab85dcc893756c7060f16437/4-Table3-1.png)
Table 2 from Conversion from epoetin alfa to darbepoetin alfa: effects on patients' hemoglobin and costs to canadian dialysis centres. | Semantic Scholar
RESISTANCE TO RECOMBINANT HUMAN ERYTHROPOIETIN THERAPY - STUDIES IN EXPERIMENTAL MODELS OF ANEMIA AND CHRONIC KIDNEY DISEASE
![Dose Conversion Ratio in Hemodialysis Patients Switched from Darbepoetin Alfa to PEG-Epoetin Beta: AFFIRM Study | SpringerLink Dose Conversion Ratio in Hemodialysis Patients Switched from Darbepoetin Alfa to PEG-Epoetin Beta: AFFIRM Study | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs12325-013-0063-y/MediaObjects/12325_2013_63_Fig1_HTML.gif)
Dose Conversion Ratio in Hemodialysis Patients Switched from Darbepoetin Alfa to PEG-Epoetin Beta: AFFIRM Study | SpringerLink
![Erythropoietin and erythropoiesis stimulating agents - Debeljak - 2012 - Drug Testing and Analysis - Wiley Online Library Erythropoietin and erythropoiesis stimulating agents - Debeljak - 2012 - Drug Testing and Analysis - Wiley Online Library](https://analyticalsciencejournals.onlinelibrary.wiley.com/cms/asset/6b4b1317-92f4-46a9-a539-daf44716ab59/dta1341-fig-0001-m.jpg)
Erythropoietin and erythropoiesis stimulating agents - Debeljak - 2012 - Drug Testing and Analysis - Wiley Online Library
![Frontiers | Erythropoiesis-Stimulating Agents in the Management of Anemia in Chronic Kidney Disease or Cancer: A Historical Perspective Frontiers | Erythropoiesis-Stimulating Agents in the Management of Anemia in Chronic Kidney Disease or Cancer: A Historical Perspective](https://www.frontiersin.org/files/Articles/425662/fphar-09-01498-HTML/image_m/fphar-09-01498-i001.jpg)
Frontiers | Erythropoiesis-Stimulating Agents in the Management of Anemia in Chronic Kidney Disease or Cancer: A Historical Perspective
View of Conversion from Epoetin Alfa to Darbepoetin Alfa: Effects on Patients' Hemoglobin and Costs to Canadian Dialysis Centres | Canadian Journal of Hospital Pharmacy
![Table 2 from Conversion from epoetin alfa to darbepoetin alfa: effects on patients' hemoglobin and costs to canadian dialysis centres. | Semantic Scholar Table 2 from Conversion from epoetin alfa to darbepoetin alfa: effects on patients' hemoglobin and costs to canadian dialysis centres. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/84246e2eeb4dcef6ab85dcc893756c7060f16437/4-Table2-1.png)
Table 2 from Conversion from epoetin alfa to darbepoetin alfa: effects on patients' hemoglobin and costs to canadian dialysis centres. | Semantic Scholar
Switching from Epoetin Alpha to Darbepoetin Alpha in Japanese Hemodialysis Patients: Dose Conversion Ratio - FullText - Nephron Clinical Practice 2009, Vol. 111, No. 2 - Karger Publishers
![Conversion from epoetin alfa to darbepoetin alfa: effects on patients' hemoglobin and costs to canadian dialysis centres. | Semantic Scholar Conversion from epoetin alfa to darbepoetin alfa: effects on patients' hemoglobin and costs to canadian dialysis centres. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/84246e2eeb4dcef6ab85dcc893756c7060f16437/5-Table4-1.png)
Conversion from epoetin alfa to darbepoetin alfa: effects on patients' hemoglobin and costs to canadian dialysis centres. | Semantic Scholar
![Dose Conversion Ratio in Hemodialysis Patients Switched from Darbepoetin Alfa to PEG-Epoetin Beta: AFFIRM Study | SpringerLink Dose Conversion Ratio in Hemodialysis Patients Switched from Darbepoetin Alfa to PEG-Epoetin Beta: AFFIRM Study | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs12325-013-0063-y/MediaObjects/12325_2013_63_Fig3_HTML.gif)